Effects of interleukin 4 on neonatal B lymphocyte tolerance

Biochem Biophys Res Commun. 1989 Oct 16;164(1):199-204. doi: 10.1016/0006-291x(89)91702-6.

Abstract

Perturbation of antigen receptors on mouse neonatal B cells by rabbit antimouse IgM antibody was shown to inhibit cell proliferation in response to the B cell mitogen lipopolysaccharide. When these antibody-inactivated cells were challenged with lipopolysaccharide in the presence of the helper T cell product interleukin 4, a strong proliferative response was observed. Interleukin 4 alone did not cause proliferation of the antibody-treated B cells. Pretreatment with interleukin 4 did not prevent neonatal B cell inactivation by the antibody. Our results show that neonatal B cells inactivated directly through their antigen receptors can be reactivated by the combined signals of interleukin 4 and lipopolysaccharide.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Animals, Newborn
  • B-Lymphocytes / drug effects*
  • B-Lymphocytes / immunology
  • Cell Division / drug effects
  • Interleukin-4 / pharmacology*
  • Lipopolysaccharides / pharmacology
  • Mice
  • Mice, Inbred BALB C
  • Receptors, Antigen, B-Cell / immunology

Substances

  • Lipopolysaccharides
  • Receptors, Antigen, B-Cell
  • Interleukin-4